Details for New Drug Application (NDA): 018118
✉ Email this page to a colleague
The generic ingredient in LANOXICAPS is digoxin. There are ten drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the digoxin profile page.
Summary for 018118
Tradename: | LANOXICAPS |
Applicant: | Glaxosmithkline Llc |
Ingredient: | digoxin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018118
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.2MG | ||||
Approval Date: | Jul 26, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.05MG | ||||
Approval Date: | Jul 26, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.1MG | ||||
Approval Date: | Jul 26, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018118
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-002 | Jul 26, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-001 | Jul 26, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-004 | Sep 24, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-003 | Jul 26, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription